User profiles for Michael T Henry
michael henryCork University Hospital / University College Cork Verified email at hse.ie Cited by 6052 |
Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis
Rationale: Several common and rare genetic variants have been associated with idiopathic
pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: …
pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: …
Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
Background SSc-ILD and IPF demonstrate significant morbidity and mortality. Predicting
disease progression is challenging in both diseases. Objectives We sought a serum biomarker …
disease progression is challenging in both diseases. Objectives We sought a serum biomarker …
Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants
…, SC Donnelly, J Egan, MT Henry… - American journal of …, 2023 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a rare, irreversible, and progressive
disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been …
disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been …
Statins versus placebo for people with chronic obstructive pulmonary disease
Background Chronic obstructive pulmonary disease (COPD) is a common, preventable, and
treatable respiratory disease. COPD exacerbations are associated with worse quality of life, …
treatable respiratory disease. COPD exacerbations are associated with worse quality of life, …
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD
S Nair, E Thomas, SB Pearson, MT Henry - Chest, 2005 - Elsevier
Study objectives Despite the widespread use of short-acting, inhaled β 2 -agonists in acute
exacerbations of COPD (AECOPDs), little is known about their optimal dose. The aims of this …
exacerbations of COPD (AECOPDs), little is known about their optimal dose. The aims of this …
[HTML][HTML] Bronchoscopy in the investigation of outpatients with hemoptysis at a lung cancer clinic
Background In the investigation of lung cancer, current practice in many healthcare systems
would support bronchoscopy regardless of CT findings in patients with hemoptysis. We …
would support bronchoscopy regardless of CT findings in patients with hemoptysis. We …
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis
MT Henry, S Cave, J Rendall, CM O'Connor… - European Journal of …, 2001 - nature.com
Lung disease is the direct cause of death in over 90% of cystic fibrosis (CF) patients. Excess
neutrophil elastase is an important determinant of pulmonary disease in CF. α 1-antitrypsin (…
neutrophil elastase is an important determinant of pulmonary disease in CF. α 1-antitrypsin (…
Tracheobronchial involvement with Crohn's disease
MT Henry, LA Davidson, NJ Cooke - European journal of …, 2001 - journals.lww.com
We report the case of a young woman with Crohn's disease of the bowel who presented
with a purulent tracheobronchitis and life-threatening upper airway obstruction. Fibreoptic …
with a purulent tracheobronchitis and life-threatening upper airway obstruction. Fibreoptic …
Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis
…, C O'Farrell, MJ Harrison, JA Eustace, MT Henry… - Respiratory …, 2011 - rc.rcjournal.com
BACKGROUND: Nebulized hypertonic saline is a highly effective therapy for patients with
cystic fibrosis (CF), yet 10% of patients are intolerant of hypertonic saline administered via jet …
cystic fibrosis (CF), yet 10% of patients are intolerant of hypertonic saline administered via jet …
Idiopathic pulmonary fibrosis: treatment update
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias.
Despite multiple recent clinical trials, there is no strong evidence supporting a survival …
Despite multiple recent clinical trials, there is no strong evidence supporting a survival …